Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Updated—End of COVID-19 National and Public Health Emergency — Employers’ Next Steps

      Alerts

    Alert / Employee Benefits & ERISA

    Updated—End of COVID-19 National and Public Health Emergency — Employers’ Next Steps

    Feb 7, 2023

    LinkedInX (Twitter)EmailCopy URL

    By Damian Myers, Yelena Gray and Annie Zhang

    Updated 2023-05-05

    We explore how group health plans will be impacted and what steps plan sponsors should take in advance of the Public Health Emergency and National Emergency ending.

    What’s the impact?

    • Plan sponsors will need to consider plan design options, work with third-party administrators to ensure compliance, and communicate changes to plan participants
    • To ensure a smooth transition and compliance, consult experienced benefits counsel on questions related to design requirements, effective dates, and participant communications

    DOWNLOAD

    Update: Employers' Next Steps

    May 5, 2023 Update:

    The Treasury Department recently clarified through informal comments that the “Outbreak Period,” which extended by up to one year several deadlines that affect group health plans and participants, will end on July 10. While the relevant regulatory agencies have not issued formal guidance regarding this issue since President Biden signed legislation that ended the COVID-19 National Emergency declaration as of April 10, the Treasury Department’s comments are consistent with FAQs issued by the DOL, HHS, and Treasury in March. To the extent that group health plan sponsors have communicated an earlier end date for the Outbreak Period to participants, an update may be required. We will continue to monitor the situation and provide updates accordingly (including any official changes to the July 10th date).

    April 17, 2023 Update:

    Since the release of our February 7th alert describing the end of the COVID-19 emergency declarations’ impact on group health plans, legislation has been enacted that ends the National Emergency earlier than May 11th and the relevant Departments (DOL, HHS, and Treasury) have issued a set of Frequently Asked Questions clarifying several items relating to testing and vaccine coverage, participant notifications, and “Outbreak Period” timeframes. A quick summary of these developments is provided below.

    • Legislation signed by President Biden ends the COVID-19 National Emergency effective as of April 10th. This emergency period is tied to the Departments’ “Outbreak Period” guidance that extended several ERISA-related deadlines for up to one year. Therefore, the Outbreak Period is now scheduled to end on June 9th (i.e., 60 days after the end of the National Emergency). Note that it is possible that the Departments will extend the 60-day period, but formal guidance to that effect has not been announced. We will issue updates as needed in the event such guidance is issued.
    • The Departments note that some employees currently enrolled in Medicaid or CHIP coverage could lose that coverage when the Public Health Emergency (PHE) ends, and remind employers that there is a 60-day special enrollment right for those employees to enroll in employer plans.
    • With respect to coverage of COVID tests, the Departments explain that it is possible that some tests will be collected before the end of the PHE but processed after the PHE ends. In those cases, the tests must be covered without cost sharing or other medical management techniques.
    • Upon the end of the PHE, out-of-network coverage of COVID vaccines can be subject to cost-sharing and medical management. However, the Departments explain that, in the unlikely event, a plan does not have an in-network provider that can provide these services, out-of-network claims must be processed as if received in-network.
    • The Departments also address participant notification requirements and explain the general rule that any change to a summary of benefits and coverage must be communicated at least 60 days prior to the change. Nevertheless, the Departments will deem sufficient any notice that is sent as soon as possible following the change to the summary of benefits and coverage. Further, if communications regarding the COVID coverage rules note that the changes are limited in duration (i.e., only during the PHE), then no additional notice is required. Employers should use caution, however, because if the notice explaining temporary coverage changes was issued in a prior year, a new notice regarding the end of certain benefits and coverage limited to the PHE period must be issued.

    COVID health emergencies formally ending in May — What health plan sponsors need to know

    Over the past three years, group health plans have been subject to special rules intended to enhance coverage and provide administrative relief during the COVID-19 pandemic. These rules are generally either tied to the declaration of COVID-19 as a Public Health Emergency (first declared by the Department of Health and Human Services as of January 27, 2020, and extended every ninety (90) days thereafter) or National Emergency (first declared by the previous administration on March 13, 2020, and renewed annually thereafter). On January 30, 2023, the Biden White House announced its intent to end both the public health emergency and national emergency on May 11, 2023. Following a brief summary of the special plan rules, this alert explains how group health plans will be impacted when those rules end and what steps plan sponsors should take in advance of May 11.

    Summary of COVID-19 special plan rules

    The Families First Coronavirus Response Act of 2020 required group health plans to expand coverage for all COVID-19-related testing ordered by a participant’s physician. This first-dollar coverage applies to both in-network and out-of-network testing services, and prior authorization or other medical management techniques are not permitted. The Coronavirus Aid, Relief, and Economic Security Act of 2020 expanded coverage for COVID-19-related testing even more and required rapid coverage (both in-network and out-of-network) of COVID-19 vaccines as preventive services. In January 2022, the Departments of Labor, Treasury, and Health and Human Services issued guidance requiring group health plan coverage of at-home COVID-19 tests purchased by participants. All of these coverage rules for COVID-19 testing and vaccines are tied to the Public Health Emergency and the requirements will end on May 11.

    Effective as of March 1, 2020, the Department of Labor exercised its authority under Section 518 of the Employee Retirement Income Security Act (ERISA) and mandated that certain deadlines applicable to ERISA-covered plans are tolled until the earlier of (i) one year from the date of the applicable deadline (determined on an individual basis) or (ii) sixty (60) days after the announced end of the National Emergency. The period during which the deadline is delayed is referred to as the “Outbreak Period.” During the Outbreak Period, the following deadlines are delayed: (i) special enrollment period under HIPAA (thirty (30) or sixty (60) days, as applicable); (ii) 60-day Consolidated Omnibus Budget Reconciliation Act (COBRA) election period; (iii) COBRA premium payment due date; (iv) deadline for qualified beneficiaries under COBRA to notify the plan administrator of a qualifying event; (v) deadline for a plan to provide COBRA election notices; (vi) claims and appeals filing deadlines; and (vii) deadlines related to external review of claims. These administrative rules will end on July 10, sixty (60) days after the end of the National Emergency.

    Action items for plan sponsors

    In connection with the end of the Public Health and National Emergencies, plan sponsors will need to consider plan design options, work with third-party administrators to ensure compliance, and communicate changes to plan participants.

    Plan design: COVID-19 testing

    During the Public Health Emergency, COVID-19 testing must be covered at first-dollar at both in-network and out-of-network levels of coverage. Once the Public Health Emergency ends, employers can cover COVID-19 in the same manner as any other diagnostic test. Sponsors should consider how coverage will be applied when a test is given during an office visit or when a physician sends the test to a lab. Consideration should also be given to how voluntary, or at-home testing will be treated under plans. Although over-the-counter diagnostic tests are eligible medical expenses (and reimbursable under health savings accounts (HSAs), health reimbursement arrangements (HRAs), and flexible spending accounts (FSAs)), most major medical group health plans do not cover over-the-counter products.

    Plan design: Vaccines

    COVID-19 vaccines are covered as preventive services under the Affordable Care Act (ACA). The standard requirement under the ACA is that preventive services must be covered at first-dollar only when obtained from an in-network provider or facility. During the Public Health Emergency, COVID-19 vaccines must be covered at first-dollar whether in-network or not. Plans should consider whether to modify the current rules to bring COVID-19 vaccine coverage back in-line with coverage of other preventive services.

    Coordination with third-party administrators

    Plan sponsors should contact their third-party plan administrators to ensure that procedures are in place to modify coverage requirements at the end of the public health and national emergencies. With respect to COVID-19 testing and vaccines, sponsors should ensure that coverage can be timely modified and whether the sponsor or administrator will communicate the changes to plan participants. Similarly, with respect to the Outbreak Period administrative rules, sponsors should confirm that administrators can reinstate the applicable deadlines by July 10 and communicate as needed to relevant participants.

    Participant communications

    Given that most of the coverage and administrative rules have been in place for almost three years, participant communication is key to mitigate potential disputes. To the extent that summary plan descriptions have been modified to reflect any of the COVID-19-related rules, a summary of material modifications should be sent to participants within sixty (60) days of the change. Even if the summary plan description does not describe the COVID-19 rules, it is still recommended, from an ERISA fiduciary perspective, that plans notify plan participants of the changes.

    Special consideration should be given to the employee population that receives the communications. Certainly, active plan participants (including COBRA enrollees) should be informed. Also, former employees who might be eligible for COBRA during the Outbreak Period (generally, anyone who lost coverage with a COBRA election right within the prior twelve (12) months) should receive notice that the Outbreak Period is ending. Also, because HIPAA special enrollment deadlines are delayed during the Outbreak Period, employees who have not enrolled in the plan should receive the notice in case they had a special enrollment right within the past twelve (12) months. With these nuances, the best approach may be to send the notice to all active employees and any former employee who had COBRA election rights within the 12-month period ending on July 10, 2023.

    Plan sponsors and administrators should also review existing COBRA notices in advance of July 10. Many administrators modified standard COBRA election forms to reflect the special extended timelines for COBRA notifications, elections, and premium payments. Now, plan sponsors and administrators should work with their third-party COBRA administrators to modify the election forms and remove references to the extended timeframes.

    Outlook

    For most plan sponsors, the end of the Public Health and National Emergencies is a welcome development from a health plan management perspective. First-dollar coverage of COVID-19 tests, particularly at-home tests, has been a significant cost driver under most plans. Additionally, the Outbreak Period administrative deadline delays have been difficult to navigate (especially with respect to COBRA premium payments). As plan sponsors prepare to return to the old normal, benefits counsel should be consulted on questions related to design requirements, effective dates, and participant communications.

    Practices

    Employee Benefits & ERISAEmployee Benefit Plan AuditsLabor, Employment & BenefitsOccupational Safety & Health (OSHA)Workplace Policies, Procedures & Training

    Insights And Happenings

    • Alert

      Fiduciary governance: Managing increasing health and welfare fiduciary risks

      Sep 14, 2023
    • Alert

      NLRB reverses course and expands protections for employee misconduct

      May 9, 2023
    • Alert

      No gag clauses — attestation is due by year-end

      April 5, 2023
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved